ArticleJournal for immunotherapy of cancer2018

An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides.

Laura L Eggink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.